97 related articles for article (PubMed ID: 38463758)
1. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
Gutierrez-Guerrero A; Cosset FL; Verhoeyen E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933033
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.
Holbrook MC; Goad DW; Grdzelishvili VZ
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803211
[TBL] [Abstract][Full Text] [Related]
3. Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells.
Grygoryev D; Ekstrom T; Manalo E; Link JM; Alshaikh A; Keith D; Allen-Petersen BL; Sheppard B; Morgan T; Soufi A; Sears RC; Kim J
Heliyon; 2024 Mar; 10(5):e27221. PubMed ID: 38463758
[TBL] [Abstract][Full Text] [Related]
4. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
[TBL] [Abstract][Full Text] [Related]
5. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
Goad DW; Nesmelova AY; Yohe LR; Grdzelishvili VZ
J Virol; 2023 Sep; 97(9):e0100523. PubMed ID: 37671865
[TBL] [Abstract][Full Text] [Related]
6. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.
Felt SA; Droby GN; Grdzelishvili VZ
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566376
[TBL] [Abstract][Full Text] [Related]
7. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent.
Janssens W; Chuah MK; Naldini L; Follenzi A; Collen D; Saint-Remy JM; VandenDriessche T
Hum Gene Ther; 2003 Feb; 14(3):263-76. PubMed ID: 12639306
[TBL] [Abstract][Full Text] [Related]
9. Restoring tumor immunogenicity with dendritic cell reprogramming.
Zimmermannova O; Ferreira AG; Ascic E; Velasco Santiago M; Kurochkin I; Hansen M; Met Ö; Caiado I; Shapiro IE; Michaux J; Humbert M; Soto-Cabrera D; Benonisson H; Silvério-Alves R; Gomez-Jimenez D; Bernardo C; Bauden M; Andersson R; Höglund M; Miharada K; Nakamura Y; Hugues S; Greiff L; Lindstedt M; Rosa FF; Pires CF; Bassani-Sternberg M; Svane IM; Pereira CF
Sci Immunol; 2023 Jul; 8(85):eadd4817. PubMed ID: 37418548
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.
Linde MH; Fan AC; Köhnke T; Trotman-Grant AC; Gurev SF; Phan P; Zhao F; Haddock NL; Nuno KA; Gars EJ; Stafford M; Marshall PL; Dove CG; Linde IL; Landberg N; Miller LP; Majzner RG; Zhang TY; Majeti R
Cancer Discov; 2023 May; 13(5):1164-1185. PubMed ID: 36856575
[TBL] [Abstract][Full Text] [Related]
11. Direct Reprogramming of Different Cell Lineages into Pancreatic β-Like Cells.
Colarusso JL; Zhou Q
Cell Reprogram; 2022 Oct; 24(5):252-258. PubMed ID: 35838597
[TBL] [Abstract][Full Text] [Related]
12. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma.
Hayashi A; Fan J; Chen R; Ho YJ; Makohon-Moore AP; Lecomte N; Zhong Y; Hong J; Huang J; Sakamoto H; Attiyeh MA; Kohutek ZA; Zhang L; Boumiza A; Kappagantula R; Baez P; Bai J; Lisi M; Chadalavada K; Melchor JP; Wong W; Nanjangud GJ; Basturk O; O'Reilly EM; Klimstra DS; Hruban RH; Wood LD; Overholtzer M; Iacobuzio-Donahue CA
Nat Cancer; 2020 Jan; 1(1):59-74. PubMed ID: 35118421
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer.
Raghavan S; Winter PS; Navia AW; Williams HL; DenAdel A; Lowder KE; Galvez-Reyes J; Kalekar RL; Mulugeta N; Kapner KS; Raghavan MS; Borah AA; Liu N; Väyrynen SA; Costa AD; Ng RWS; Wang J; Hill EK; Ragon DY; Brais LK; Jaeger AM; Spurr LF; Li YY; Cherniack AD; Booker MA; Cohen EF; Tolstorukov MY; Wakiro I; Rotem A; Johnson BE; McFarland JM; Sicinska ET; Jacks TE; Sullivan RJ; Shapiro GI; Clancy TE; Perez K; Rubinson DA; Ng K; Cleary JM; Crawford L; Manalis SR; Nowak JA; Wolpin BM; Hahn WC; Aguirre AJ; Shalek AK
Cell; 2021 Dec; 184(25):6119-6137.e26. PubMed ID: 34890551
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures.
Kim J; Ekstrom T; Yang W; Donahue G; Grygoryev D; Ngo TTM; Muschler JL; Morgan T; Zaret KS
Mol Cancer Res; 2021 Nov; 19(11):1854-1867. PubMed ID: 34330844
[TBL] [Abstract][Full Text] [Related]
15. The pancreatic cancer genome revisited.
Hayashi A; Hong J; Iacobuzio-Donahue CA
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):469-481. PubMed ID: 34089011
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
